S Chen, W Sun, M Dan, Y Sun, Y Jiang - Journal of Thrombosis and …, 2023 - Springer
Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus, we aimed to develop a nomogram to predict the risk of VTE in these patients. We …
N van Es, M Di Nisio, G Cesarman, A Kleinjan… - …, 2017 - ncbi.nlm.nih.gov
In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous thromboembolism is not recommended. Several risk prediction scores to identify cancer …
D Angelini, AA Khorana - Seminars in thrombosis and …, 2017 - thieme-connect.com
Current guidelines recommend that patients with cancer be assessed for venous thromboembolism (VTE) risk at the time of chemotherapy initiation and periodically …
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung, and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …
DR Douce, CE Holmes, M Cushman… - Journal of Thrombosis …, 2019 - Elsevier
Abstract Background The Khorana Score is a validated risk score for predicting 6‐month incidence of cancer‐associated venous thromboembolism (CAT) among patients starting …
CA Cella, M Knoedler, M Hall, M Arcopinto… - JAMA network …, 2023 - jamanetwork.com
Importance The assessment of the risk of venous thromboembolism (VTE) among outpatients with cancer represents an unsolved topic. Current international guidelines …
The Asian population is thought to have a low risk of venous thromboembolism (VTE), but the epidemiology of VTE in cancer patients remains unclear. The National Health Insurance …
M Dutia, RH White, T Wun - Cancer, 2012 - Wiley Online Library
Venous thromboembolism (VTE) is common in cancer patients, and is associated with significant morbidity and mortality. Several factors, including procoagulant agents secreted …
PURPOSE Venous thromboembolism (VTE), especially pulmonary embolism (PE) and lower extremity deep vein thrombosis (LE-DVT), is a serious and potentially preventable …